’First in man’: The politics and ethics of women in clinical drug trials

Feminist Review

Volumn 72, Issue 1, 2002, Pages 40-52

  Corrigan, Oonagh P ^a  

^a NONE

Author keywords

Clinical drug trials; Drug regulation; Ethic; Women health

Indexed keywords

EID: 84937380394     PISSN: 01417789     EISSN: 14664380     Source Type: Journal    
DOI: 10.1057/palgrave.fr.9400055     Document Type: Article

References (31)

1. Association of the British Pharmaceutical Industry (1994) ’Guidelines for medical experiments in non-patient human volunteers’ in C.G. Foster (1994) editor, Manual for Research Ethics Committees, London: The Centre of Law and Medical Ethics, Kings College.
2. Beauchamp, T. and Childress, J. (1989) Principles of Biomedical Ethics, New York: Oxford University Press.
3. Beecher, H. (1970) Research and the Individual Human Studies, Boston: Little Brown.
4. Beierle, I., Meibohm, B. and Derendorf, H. (1999) ’Gender differences in pharmacokinetics and pharmacodynamics’ International Journal of Clinical Pharmacology and Therapeutics, Vol. 37, No. 11: pp.529-547.
5. Bennett, C.J. (1993) ’ Inclusion of women in clinical trials - policies for population subgroups’. New England Journal of Medicine, Vol. 329, No. 4: pp.228-291.
6. Bush, J.K. (1994) ’The industry perspective on the inclusion of women in clinical trials’. Academic Medicine, Vol. 69, No. 9: pp.708-715.
7. Capron, A.M. (1989) ’Human experimentation’. in R. Veatch (1989) editor, Medical Ethics, Boston: Jones and Bartlet Publishers.
8. Corrigan, O. (2002) ’A risky business: the detection of adverse drug reactions in clinical trials and post-marketing exercises’. Social Science and Medicine, No. 35: pp.497-502
9. Council for International Organizations of Medical Science (1993) International Ethical Guidelines for Biomedical Research Involving Human Subjects, Geneva: CIOMS.
10. Department of Health (1991) Local Research Ethics Committees, HSG (91)5, Heywood: DOH Store, Health Publications Unit.
11. Department of Health and Human Services, F.A.D.A. (1993) ’Guideline for the study and evaluation of gender differences in the clinical evaluation of drugs’, Federal Register, Vol. 58, No. 139: pp.39406-39416.
12. Epstein, S. (1996) Impure Science, London: University of California Press.
13. Epstein, S. (1997) ’Activism, drug regulation, and the politics of therapeutic evaluation in the AIDS era: a case study of ddC and the ”surrogate markers” debate’, Scoial Studies of Science, 27, pp.691-726.
14. Griffin, J.P., O’Grady, J. and Wells, F.O. (1993) The Textbook of Pharmaceutical Medicine, Belfast: The Queen’s University of Belfast.
15. Grubb, A. (1997) ’The law relating to consent’ in C.G Foster (1997) editor, Manual for Research Ethics Committees, London: The Centre of Medical Law and Ethicks, Kings Colleage.
16. Johnson, T.L. and Fee, E. (1997), ’Women’s health research: a historical perspective’, in F. P Haseltine and B.G. Jacobson (1997) editors, Women’s Health Research: A Medical and Policy Primer, Washington: Health Press International.
17. Lazarou, J., Pomeranz, B.H. and Corey, P.N. (1998) ’Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies’ Journal of the American Medical Association, Vol. 279, pp.1200-1205.
18. Merkatz, R.B. and Summers, E.I. (1997) ’Including women in clinical trials: policy changes at the Food and Drug Administration’, in F.P. Haseltine and B.G. Jacobson (1997) editors, Women’s Health Research: A Medical and Policy Primer, Washington: Health Press International.
19. Office of Women’s Health (2001) FDA milestones in women’s health: looking back as we move into the new millennium, http://www.fda.gov/womens/milesbro.html
20. Pappworth, M. (1967) Human Guinea Pigs, Middlesex: England, Pelican.
21. Rothman, D.J. (1991) Strangers at the Bedside, USA: Basic Books.
22. Rothman, D.J. and Edgar, H. (1990) ’New rules for new drugs: the challenge of AIDS to the regulatory process’ Milbank Quarterly Supplement, Vol. 68, No. 1: pp.111-142.
23. Rowley-Jones, D. and Nicholson, P. (1993) ’Development of medicines: full development’, in J.P. Griffin, F. O’Grady and F.O.Wells (1993) editors, The Textbook of Pharmaceutical Medicine, Belfast: Queen’s University of Belfast.
24. Royle, J.M. and Snell, E.S. (1986) ’Medical research on normal volunteers’, British Journal of Clinical Pharmacology, Vol. 21, pp. 548-549.
25. Sheppard, A (1999) ’ US Food and Drug Administration Office of Women’s Health: update’ Journal of American Medical Women’s Association, Vol. 54, No. 2: pp.97-98.
26. Spiker, B. (1991) Guide to Clinical Trials, New York: Raven Press.
27. The Royal College of Physicians (1990) A Report of the Royal College of Physicians: Research involving Patients, London: The Royal College of Physicians.
28. Veatch, R. (1977) Case Studies in Medical Ethics, Harvard: Harvard University Press.
29. Wolpe, P. (1998) ’The triumph of autonomy in American bioethics: a sociological view’ in R. DeVries and J. Subedi, (1998) editors, Bioethics and Society, New Jersey: Prentice-Hall.
30. Working Party on Ethical Aspects of AIDS Vaccine Trials (1991) Ethical Conduct of AIDS Vaccine Trials, London: Medical Research Council.
31. Yonkers, K., Kando, J., Cole, J. and Blumenthal, S. (1993) ‘Gender differences in pharmacokinetics and pharmacodynamics of psychotropic medication’, American Journal of Psychiatry, Vol. 150, No. 4, 678-679.